EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy

Giovanna Gallo iD, Oreste Lanza, Carmine Savoia iD

International Journal of Molecular Sciences · 07.03.2023 · 24 (6) · 5089

DOI: 10.3390/ijms24065089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.03.2023. Verfasst von Giovanna Gallo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Molecular Medicine Department, Faculty of Medicine and Psychology, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy. Hauptthemen laut MEDLINE: Cardio-Renal Syndrome, Heart Failure. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiorenal syndrome consists in the coexistence of acute or chronic dysfunction of heart and kidneys resulting in a cascade of feedback mechanisms and causing damage to both organs associated with high morbidity and mortality. In the last few years, different biomarkers have been investigated with the aim to achieve an early and accurate diagnosis of cardiorenal syndrome, to provide a prognostic role and to guide the development of targeted pharmacological and non-pharmacological therapies. In such a context, sodium-glucose cotransporter 2 (SGLT2) inhibitors, recommended as the first-line choice in the management of heart failure, might represent a promising strategy in the management of cardiorenal syndrome due to their efficacy in reducing both cardiac and renal outcomes. In this review, we will discuss the current knowledge on the pathophysiology of cardiorenal syndrome in adults, as well as the utility of biomarkers in cardiac and kidney dysfunction and potential insights into novel therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardio-Renal SyndromeHeart FailureHumansKidneyHeartBiomarkers

Stichwörter der Autor:innen

SGLT2 inhibitorsheart failurerenal disease

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Clinical and Molecular Medicine Department, Faculty of Medicine and Psychology, Sant'Andrea Hospital, Sapienza University of Rome, 00189 Rome, Italy.

ORCID-Profile: Giovanna Gallo, Carmine Savoia

Zitieren

APA

Gallo, G., Lanza, O., & Savoia, C. (2023). New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy. International Journal of Molecular Sciences, 24(6), 5089. https://doi.org/10.3390/ijms24065089

Vancouver

Gallo G, Lanza O, Savoia C. New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy. International Journal of Molecular Sciences. 2023;24(6):5089. doi:10.3390/ijms24065089

BibTeX
@article{Gallo2023,
  author = {Gallo, Giovanna and Lanza, Oreste and Savoia, Carmine},
  title = {New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {6},
  pages = {5089},
  doi = {10.3390/ijms24065089}
}
Kostenlos starten →